Influence of age, frailty and liver func
β
J. Zeeh; W. Bergmann; D. Platt; L. Fuchs; K.-H. Antonin; P. Bieck; F. Degel
π
Article
π
1996
π
Springer
π
English
β 450 KB
Objective: The pharmacokinetics of brofaromine, a selective inhibitor of monoamine oxidase A, was evaluated in 12 frail elderly patients (66 92 y) and 12 healthy volunteers (20-35 y). Methods': Quantitative liver function tests were performed to show whether brofaromine elimination in the elderly co